510(k) · Cleared
ClearedThixo-Gel Ultrasound Spray
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cloverline International Pharma Services GmbH · MUI Media, Coupling, Ultrasound
Cleared on Aug 30, 2012 as substantially equivalent to K802146 (Parker Laboratories, Inc., 1980) after a 121-day review. Its family tree reaches back 1 generation to 1980. 2 later devices descend from it.
- Decided
- Aug 30, 2012
- Review
- 121 days
- Class
- Class II
- Product code
- MUI
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K802146 (1980). 2 later devices descend from it, 1 citing it directly.
- Root · 1 generation backK802146 Aquasonic 100 Ultrasound Trans. Gel,Parker Laboratories, Inc. · 1980 · Recalled
- This deviceK121311 Thixo-Gel Ultrasound SprayCloverline International Pharma Services GmbH · 2012
- Descendant · cites it directly · 1 of its ownK131905 Solid Gel PadBluemtech · 2013
- Descendant · 2 generations on · 0 of its ownK252337 EdgeFlow Gel PadEdgecare, Inc. · 2026
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K802146 | Aquasonic 100 Ultrasound Trans. Gel, | Parker Laboratories, Inc. | 1980 | 1 |
| 0 (this device) | K121311 | Thixo-Gel Ultrasound Spray | Cloverline International Pharma Services GmbH | 2012 | — |
| +1 | K131905 | Solid Gel Pad | Bluemtech | 2013 | — |
| +2 | K252337 | EdgeFlow Gel Pad | Edgecare, Inc. | 2026 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MUI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MUI device
- #1 K253255 Non-Sterile Ultrasound Gel Sterile Ultrasound…score 12.4 · 4 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K802146 | Aquasonic 100 Ultrasound Trans. Gel,Summary page 2…ugust Thixo-gel page I 5. Substanftial Equivaiedice' Information: A. Predicate device name; Aquasonid 00® B. Predicate device K numiber: 802146 - C.Coparison with predicate: SUBSTANTIAL THixo-GEL 7AQuASONIC 100 0 EQUIVALENCE TA… | 1980 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K131905 | Solid Gel Pad | 2013 | 1 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All MUI devicesMUI Media, Coupling, Ultrasound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · MUI
2in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · MUI
434in 2018
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MUI
1in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MUI
25in 2025
MAUDE reports naming product code MUI, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 2 |
| 2009 | 1 | — | 0 | 2 |
| 2010 | 0 | — | 0 | 6 |
| 2011 | 2 | — | 0 | 0 |
| 2012 | 2 | — | 2 | 1 |
| 2013 | 2 | — | 0 | 1 |
| 2014 | 1 | — | 0 | 2 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 1 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 0 |
| 2018 | 5 | 434 | 0 | 2 |
| 2019 | 1 | — | 0 | 2 |
| 2020 | 0 | — | 0 | 2 |
| 2021 | 1 | — | 0 | 13 |
| 2022 | 1 | — | 0 | 1 |
| 2023 | 1 | — | 1 | 2 |
| 2024 | 2 | — | 0 | 2 |
| 2025 | 0 | — | 0 | 25 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
Thixo-Gel Ultrasound Spray® is used as an ultrasound coupling medium for
diagnostic and therapeutic procedures on external, intact skin for a short duration.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K121311 · printed Nov 6, 2026
Cite this page
510(k) Report. “K121311: Thixo-Gel Ultrasound Spray.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121311
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026